Print Issue: March 01, 2007

New Blood Test Can Diagnose Severe BPH

Researchers have developed a new blood test that can distinguish severely symptomatic BPH from BPH that occurs with few if any symptoms, even if men have prostate cancer. The assay measures serum levels of a protein called JM-27.

Histologic Improvements Documented

WASHINGTON, D.C.—The histologic changes that occur in patients with severe proliferative lupus nephritis following treatment with rituximab (Rituxan) plus cyclophosphamide may be seen, researchers say.

Screening Cuts Risk of Advanced PCa

Biennial PSA screening decreases the likelihood of being diagnosed with metastatic prostate cancer, but nearly doubles the chance of being diagnosed with prostate cancer of any type, a Swedish sudy found.

Anthony J. Bleyer, MD, MS

Genetic Renal Disease Easily Missed

Autosomal dominant interstitial kidney disease is an under-recognized cause of kidney failure. Characterized by a very strong family history of kidney disease, it is a slowly progressive condition that leads to dialysis when patients are in their 40s or older.

Renal Function at Biopsy Is Key

WASHINGTON, D.C.—The best predictor of outcome in patients with lupus nephritis is kidney function at the time of renal biopsy, supporting the need for early diagnosis and treatment, researchers reported here at the American College of Rheumatology annual meeting.

Next post in Malpractice News